Edition:
United Kingdom

Molecular Templates Inc (MTEM.OQ)

MTEM.OQ on NASDAQ Stock Exchange Capital Market

5.47USD
21 Sep 2018
Change (% chg)

$-0.32 (-5.53%)
Prev Close
$5.79
Open
$5.82
Day's High
$5.98
Day's Low
$5.25
Volume
473,692
Avg. Vol
46,259
52-wk High
$13.25
52-wk Low
$4.02

Latest Key Developments (Source: Significant Developments)

Molecular Templates Inc Announces Pricing Of Public Offering Of Common Stock
Friday, 21 Sep 2018 

Sept 20 (Reuters) - Molecular Templates Inc ::MOLECULAR TEMPLATES, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.MOLECULAR TEMPLATES -PRICING OF ITS UNDERWRITTEN PUBLIC OFFERING OF 8,200,000 SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING PRICE OF $5.50 PER SHARE.  Full Article

Molecular Templates Announces Deal With Takeda
Wednesday, 19 Sep 2018 

Sept 19 (Reuters) - Molecular Templates Inc ::MOLECULAR TEMPLATES ANNOUNCES AGREEMENT WITH TAKEDA FOR THE JOINT DEVELOPMENT OF A PROTEIN-BASED ONCOLOGY THERAPY.MOLECULAR TEMPLATES INC - TAKEDA WILL MAKE AN UPFRONT PAYMENT OF $30 MILLION.MOLECULAR TEMPLATES - CO ELIGIBLE TO RECEIVE DEVELOPMENT, OTHER MILESTONE PAYMENTS OF UPTO $632.5 MILLION IF CO EXERCISES ITS CO-DEVELOPMENT OPTION.MOLECULAR TEMPLATES - ELIGIBLE TO RECEIVE DEVELOPMENT, OTHER MILESTONE PAYMENTS OF $337.5 MILLION IF IT DOESN'T EXERCISE OR OPTS OUT OF CO-DEVELOPMENT OPTION.MOLECULAR TEMPLATES INC - TAKEDA HAS ALSO AGREED TO PAY ROYALTIES ON SALES OF COMMERCIAL PRODUCT DEVELOPED THROUGH COLLABORATION.MOLECULAR TEMPLATES - AGREEMENT WITH TAKEDA PHARMACEUTICAL COMPANY LIMITED FOR JOINT DEVELOPMENT OF CD38-TARGETED ENGINEERED TOXIN BODIES.  Full Article

Molecular Templates Q1 Loss Per Share $0.32
Monday, 14 May 2018 

May 14 (Reuters) - Molecular Templates Inc ::MOLECULAR TEMPLATES, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.32.Q1 REVENUE $500,000 VERSUS $1.9 MILLION.CURRENT CASH BALANCE IS EXPECTED TO FUND OPERATIONS INTO LATE 2019.  Full Article

Molecular Templates Provides Corporate Update And Outlines 2018 Milestones
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Molecular Templates Inc ::MOLECULAR TEMPLATES PROVIDES CORPORATE UPDATE AND OUTLINES 2018 MILESTONES.MOLECULAR TEMPLATES INC - ‍ EXPECTED TO FILE IND FOR HER2 AND/OR PD-L1 PROGRAMS BUSINESS DEVELOPMENT IN Q4 2018​.MOLECULAR TEMPLATES INC - EXPECTS TO FILE IND FOR HER2 AND/OR PD-L1 PROGRAMS IN Q4 2018.  Full Article

Molecular Templates appoints Adam Cutler as CFO
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Molecular Templates Inc :Molecular Templates strengthens management team with appointment of Adam Cutler as Chief Financial Officer.Molecular Templates Inc - ‍announced appointment of Adam Cutler as Chief Financial Officer, effective Monday, November 13, 2017​.  Full Article

Molecular Templates Q3 loss per share $0.62
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Molecular Templates Inc ::Molecular Templates, Inc. Reports third quarter 2017 financial results.Q3 revenue $600,000.Q3 loss per share $0.62.Molecular Templates Inc - ‍MT-3724 advancing in clinical trials with new data expected in 1H18​.  Full Article

AbCheck and Molecular Templates collaborate to discover therapeutic oncology leads
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Molecular Templates Inc ::Says Abcheck will use Absieve discovery platform to deliver antibodies against biological targets selected by Molecular Templates​.Says ‍further details were not disclosed​.  Full Article

Molecular Templates files for sale of 11.6 mln shares of common stock by selling stockholders‍​
Saturday, 16 Sep 2017 

Sept 15 (Reuters) - Molecular Templates Inc :Molecular Templates Inc - files for sale of 11.6 million shares of common stock by selling stockholders - sec filing‍​.  Full Article

BRIEF-Molecular Templates Reports Qtrly Loss Per Share ‍$0.26​

* MOLECULAR TEMPLATES, INC. REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS